On January 7, 2021 Cancer Genetics, Inc. (the "Company") (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, reported that Jay Roberts, Chief Executive Officer, will present at the 2021 BioConnect Virtual Conference hosted by H.C. Wainwright (Press release, Cancer Genetics, JAN 7, 2021, View Source [SID1234573631]). Registered attendees can access the recorded presentation on-demand (24×7) for the duration of the conference.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Date: January 11-14, 2021 (Monday-Thursday)
On-Demand Starts: 6:00am ET – Monday, January 11, 2021
On-Demand Ends 9:00pm ET- Thursday, January 14, 2021
Registration: View Source
Mr. Roberts will highlight the Company’s recent transformational business strategy, discuss near-term events including the Company’s proposed merger with StemoniX, Inc., and the broader corporate vision of the Company going forward.
CGIX will be available for virtual 1:1 meetings both during and after the BioConnect Conference. Please contact Jennifer K. Zimmons, Ph.D. [email protected] 917.214.3514 for scheduling.